| Literature DB >> 33619962 |
Frederico Campos Freitas1, Paulo Henrique Borges Ferreira1, Denize Cristina Favaro2, Ronaldo Junio de Oliveira1.
Abstract
Angiotensin-converting enzyme 2 (Entities:
Mesh:
Substances:
Year: 2021 PMID: 33619962 PMCID: PMC7931628 DOI: 10.1021/acs.jcim.0c01320
Source DB: PubMed Journal: J Chem Inf Model ISSN: 1549-9596 Impact factor: 4.956
Figure 1SARS-CoV-1 and SARS-CoV-2 spike proteins inhibited by ACE2-based peptides. (A) Coronavirus uses the surface spike protein (in red) to lock onto human ACE2 receptors (in gray) located on the surface of host cells to deliver its RNA to produce more viruses. (B) Closer virus–host interface look is shown, represented by the spike receptor-binding domain (RBD, in cyan) and the ACE2 peptidase domain (PD, in light gray). The residues of ACE2-PD interfacing with spike-RBD (in green) are also shown, which were used as one designed peptide with the aim to inhibit the virus–cell recognition schemed in (C). Human ACE2-based peptides binding to spike-RBD of (D) SARS-CoV-1 and (E) SARS-CoV-2 with the spike receptor-binding motif (RBM) is shown in red. The residue sequences of each extracted ACE2 peptide are presented in green in (D) and (E): α1-helix composed of residues 22–44, 22–57, and residues 22–44 of α1 connect by one glycine (G) with the loop region numbering from 351 to 357; inhibitors 1, 2, and 3 for sort.
Figure 2Hydrogen bonds formed by (A) SARS-CoV-1 (CoV1) and (B) SARS-CoV-2 (CoV2) and the inhibitors 1, 2, and 3. Only the side chains of residues involved in hydrogen bonds are evidenced, and the hydrogen bond formed by the residue K417 (CoV2) and D30 of the inhibitors is highlighted in dark blue.
Percentage of Minimally, Neutral, and Highly Mutational and Configurational Frustration Indexes of Interface Contacts between SARS-CoV-1 and 2 and the Inhibitors 1, 2, and 3
| CoV1+ | 11 (26.2%) | 18 (42.9%) | 13 (31.0%) | 42 (100%) |
| CoV2+ | 7 (13.0%) | 33 (61.1%) | 14 (25.9%) | 54 (100%) |
| CoV1+ | 14 (29.2%) | 21 (43.8%) | 13 (27.1%) | 48 (100%) |
| CoV2+ | 11 (18.6%) | 34 (57.6%) | 14 (23.7%) | 59 (100%) |
| CoV1+ | 13 (16.5%) | 49 (62.0%) | 17 (21.5%) | 79 (100%) |
| CoV2+ | 12 (14.3%) | 60 (71.4%) | 12 (14.3%) | 84 (100%) |
Figure 3Free energy (F) of simulated ACE2 peptide binding to SARS-CoV-1 (red) and SARS-CoV-2 (orange) spike-RBD proteins. One-dimensional F profiles are shown as a function of reaction coordinates: a fraction of native (A) peptide–protein chain interface contacts (Qbind), (B) inter plus intrachain contacts (Qtotal), and (C) peptide contacts (Qpeptide). (D, E) show two-dimensional F profiles as a function of native contacts Qbind and Qpeptide. In (A), the designed peptide ACE22-44G351-357 (inhibitor 3) binds to the SARS-CoV-2 protein with a higher F barrier when compared with the α1-helix peptide ACE22-57 (peptide 2) binding to the SARS-CoV-1 spike domain. (C) shows that fragment 3 folds through a two-state mechanism upon binding to SARS-CoV-2 RBD, in contrast to a one-state (downhill) folding mechanism of 2 binding to the CoV1 surface. In addition, the coupled binding–folding processes are more cooperative to the designed 3 (E) than the natural 2 (D), despite the fact that the crossing barrier for 3 is higher and bumpier. F profiles are in units of kBTbind, with Tbind being the respective system’s binding temperature.
Figure 4Two-dimensional free energy (F) of ACE2 peptides binding to the SARS-CoV-1 (left panel) and the SARS-CoV-2 (right panel) spike proteins. (A) Root-mean-square fluctuation (rmsf) of the peptides in the native (N) state. In the right panel, the rmsf for the designed peptide in the encounter complex (E) state is also shown (dash line). Representative simulated structures in these states (gray) are aligned with the native dimer structure (colored). F profiles are shown as a function of reaction coordinates of the native (B) peptide (Qpeptide) and protein (Qspike) contacts and (C) inter plus intramolecular contacts (Qtotal) and Qpeptide. The designed peptide ACE22-44G351–357 (inhibitor 3) folds via a two-state mechanism (monitored by Qpeptide) upon binding to the SARS-CoV-2 RBD, which is oscillating in the protein native state (monitored by Qspike); in contrast to a downhill folding mechanism of ACE22-57 (inhibitor 2) binding to the SARS-CoV-1 protein. Also, the rmsf of CoV1+2 is higher than CoV2+3. F profiles are in units of kBTbind, with Tbind being the respective system binding temperature.
Figure 5Contact formation probability as a function of (A) binding (Qbind) and (B) peptide (Qpeptide) native contacts of each peptide atom i (p(Q, i)) for CoV1+2 (left panel) and CoV2+3 (right panel). The atom numbers were replaced by the respective residue number to a better visualization. The normalized contact probability increases from zero (blue) to 1 (red). Both cases were analyzed at the respective binding temperature Tbind. For each dimer, the free-energy profile (F/kBT) as a function of (A) Qbind and (B) Qpeptide with the transition state (TS) area shaded in gray is also shown. Main native contact interactions involved in the early binding event are marked in the structures at the left side of each panel in (A). Peptide inhibitor 2 binds and folds to CoV1 by the N-terminal portion of its α-helix. Fragment 3 also attempts to bind to CoV2 by the N-terminal portion at the transition state (right panel in A); however, after crossing TS, 3 unbinds its N-terminal region and binds and folds via its C-terminal loop segment.
Figure 6(A) Equilibrium dissociation constant (KD) as a function of temperature for two simulated dimers: CoV1+2 (red) and CoV2+3 (orange). KD was calculated using eq (circles) and the line represents a simple linear fit to the data that helps to guide the eye. CoV2+3 has lower dissociation constants for increasing T than CoV1+2, implying higher binding affinity in temperatures around Tbind. (B) Free energy (F) as a function of the distance between the center of mass of the protein and the peptide at Tbind. At T = Tbind in (A), the CoV2+3 equilibrium KD is about one order of magnitude smaller than CoV1+2, which is a reflection of the higher ΔF stability between bound/unbound states in (B). Temperature is normalized by the respective dimer binding temperature (T/Tbind) and F profiles are in units of kBTbind.
Equilibrium Dissociation Constant (KD) between the SARS-CoV-1 and 2 Spike-RBDs and the Peptide Inhibitors 1, 2, and 3, Evaluated at the Binding Temperature (Tbind) of Each Protein Dimer
| CoV1+ | 1.5 × 10–2 |
| CoV1+ | 3.7 × 10–2 |
| CoV1+ | 1.4 × 10–2 |
| CoV2+ | 2.7 × 10–3 |
| CoV2+ | 1.6 × 10–3 |
| CoV2+ | 6.6 × 10–3 |
Figure 7Scheme of the binding and folding dynamics of the studied dimers with the natural peptides 1 and 2 and the designed fragment 3. (A) Schematic free energy as a function of a joint binding and folding reaction coordinate. (B) Schematic diagram projecting the association mechanisms in two-dimensional binding and folding reaction coordinates. The natural and designed peptides bind prior to folding, although the designed fragment has a more cooperative binding–folding mechanism due to its two-state folding mechanism.